Ling‐Yi Kong

11.6k total citations
375 papers, 9.8k citations indexed

About

Ling‐Yi Kong is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Ling‐Yi Kong has authored 375 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 228 papers in Molecular Biology, 77 papers in Plant Science and 66 papers in Pharmacology. Recurrent topics in Ling‐Yi Kong's work include Natural product bioactivities and synthesis (106 papers), Phytochemistry and Biological Activities (43 papers) and Chromatography in Natural Products (38 papers). Ling‐Yi Kong is often cited by papers focused on Natural product bioactivities and synthesis (106 papers), Phytochemistry and Biological Activities (43 papers) and Chromatography in Natural Products (38 papers). Ling‐Yi Kong collaborates with scholars based in China, Japan and United Kingdom. Ling‐Yi Kong's co-authors include Jian‐Guang Luo, Xiaobing Wang, Junsong Wang, Jun Luo, Chao Zhang, Ming‐Hua Yang, Lei Yang, Xuefeng Huang, Yuan‐Zheng Xia and Jianguang Luo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Ling‐Yi Kong

370 papers receiving 9.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ling‐Yi Kong China	50	5.2k	1.9k	1.9k	1.4k	1.4k	375	9.8k
Hermann Stuppner Austria	51	5.3k 1.0×	1.8k 0.9×	3.7k 2.0×	1.1k 0.7×	1.4k 0.9×	358	11.5k
Jae Sue Choi South Korea	65	6.8k 1.3×	2.9k 1.5×	3.5k 1.8×	1.4k 1.0×	2.0k 1.4×	446	16.2k
Hyun Ah Jung South Korea	52	3.4k 0.6×	1.6k 0.8×	1.6k 0.9×	772 0.5×	985 0.7×	195	8.1k
Byung Sun Min South Korea	54	5.4k 1.0×	2.8k 1.5×	2.8k 1.5×	1.1k 0.8×	1.9k 1.3×	421	10.6k
Pengfei Tu China	50	5.9k 1.1×	1.4k 0.7×	3.1k 1.6×	1.3k 0.9×	1.2k 0.8×	576	10.3k
Sam Sik Kang South Korea	62	6.6k 1.3×	1.9k 1.0×	3.5k 1.8×	1.0k 0.7×	1.9k 1.3×	265	11.9k
Yueh‐Hsiung Kuo Taiwan	60	7.0k 1.4×	2.8k 1.4×	4.0k 2.1×	1.9k 1.3×	1.9k 1.3×	616	14.6k
Harry H. S. Fong United States	57	7.4k 1.4×	1.5k 0.8×	3.3k 1.7×	1.7k 1.2×	1.7k 1.2×	258	14.2k
Shengmin Sang United States	62	3.5k 0.7×	918 0.5×	2.0k 1.1×	693 0.5×	1.7k 1.2×	242	12.6k
Takako Yokozawa Japan	59	4.9k 0.9×	1.4k 0.7×	2.1k 1.1×	601 0.4×	2.4k 1.7×	417	13.1k

Countries citing papers authored by Ling‐Yi Kong

Since Specialization

Citations

This map shows the geographic impact of Ling‐Yi Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Yi Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Yi Kong more than expected).

Fields of papers citing papers by Ling‐Yi Kong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Yi Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Yi Kong. The network helps show where Ling‐Yi Kong may publish in the future.

Co-authorship network of co-authors of Ling‐Yi Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐Yi Kong. A scholar is included among the top collaborators of Ling‐Yi Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐Yi Kong. Ling‐Yi Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yalin, Bing Liao, Qunyou Tan, et al.. (2025). A novel liver-targeted and highly selective fluorescent probe for hepatic hydrogen sulfide detection in the diagnosis of drug-induced liver injury. European Journal of Medicinal Chemistry. 291. 117640–117640. 5 indexed citations

Tang, Pengfei, et al.. (2025). Limonoid walrobsin A alleviates LPS-induced septic acute kidney injury through modulating inflammatory microenvironment by targeting G protein-coupled receptor 75. Phytomedicine. 150. 157613–157613.

Kong, Ling‐Yi, et al.. (2024). Impact of digital transformation on green and sustainable innovation in business: a quasi-natural experiment based on smart city pilot policies in China. Environment Development and Sustainability. 27(10). 24629–24657. 4 indexed citations

Luo, Zhongwen, Shang Li, Yonglei Zhang, et al.. (2023). Oxazole-4-carboxamide/butylated hydroxytoluene hybrids with GSK-3β inhibitory and neuroprotective activities against Alzheimer's disease. European Journal of Medicinal Chemistry. 256. 115415–115415. 9 indexed citations

Chen, Chen, Min Kong, Ling Zhu, et al.. (2023). Discovery and optimization of indirubin derivatives as novel ferroptosis inducers for the treatment of colon cancer. European Journal of Medicinal Chemistry. 261. 115829–115829. 12 indexed citations

Chen, Jinhu, et al.. (2022). Ginkgolide B targets and inhibits creatine kinase B to regulate the CCT/TRiC-SK1 axis and exerts pro-angiogenic activity in middle cerebral artery occlusion mice. Pharmacological Research. 180. 106240–106240. 28 indexed citations

Tang, Pengfei, Shanting Liao, Shanshan Wei, et al.. (2021). Shizukaol A exerts anti-inflammatory effect by regulating HMGB1/Nrf2/HO-1 pathway. Phytomedicine. 82. 153472–153472. 32 indexed citations

Wang, Ziwen, Yucheng Zhao, Shan Li, et al.. (2020). Functional characterization of cinnamate 4-hydroxylase from Helianthus annuus Linn using a fusion protein method. Gene. 758. 144950–144950. 10 indexed citations

Han, Chao, Xiao Xu, Can Zhang, et al.. (2020). Cytochrome c light-up graphene oxide nanosensor for the targeted self-monitoring of mitochondria-mediated tumor cell death. Biosensors and Bioelectronics. 173. 112791–112791. 19 indexed citations

10.

Gao, Hongliang, Yuan‐Zheng Xia, Yalong Zhang, Lei Yang, & Ling‐Yi Kong. (2019). Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines. Phytomedicine. 58. 152885–152885. 18 indexed citations

11.

Wang, Zhendong, Ruizhi Wang, Yuan‐Zheng Xia, Ling‐Yi Kong, & Lei Yang. (2018). Reversal of multidrug resistance by icaritin in doxorubicin-resistant human osteosarcoma cells. Chinese Journal of Natural Medicines. 16(1). 20–28. 21 indexed citations

12.

Wei, Dandan, Junsong Wang, Jin‐Ao Duan, & Ling‐Yi Kong. (2018). Metabolomic Assessment of Acute Cholestatic Injuries Induced by Thioacetamide and by Bile Duct Ligation, and the Protective Effects of Huang-Lian-Jie-Du-Decoction. Frontiers in Pharmacology. 9. 458–458. 20 indexed citations

13.

Ma, Ting, Bo‐Yi Fan, Chao Zhang, et al.. (2016). Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway. Scientific Reports. 6(1). 29926–29926. 24 indexed citations

14.

Li, Ruijun, Caiyun Gao, Chao Guo, et al.. (2016). The Anti-inflammatory Activities of Two Major Withanolides from Physalis minima Via Acting on NF-κB, STAT3, and HO-1 in LPS-Stimulated RAW264.7 Cells. Inflammation. 40(2). 401–413. 45 indexed citations

15.

Wang, Zhendong, Lei Yang, Yuan‐Zheng Xia, Chao Guo, & Ling‐Yi Kong. (2015). Icariin Enhances Cytotoxicity of Doxorubicin in Human Multidrug-Resistant Osteosarcoma Cells by Inhibition of ABCB1 and Down-Regulation of the PI3K/Akt Pathway. Biological and Pharmaceutical Bulletin. 38(2). 277–284. 45 indexed citations

16.

Wang, Junsong, et al.. (2014). Toxicity assessment of Arisaematis Rhizoma in rats by a 1H NMR-based metabolomics approach. Molecular BioSystems. 11(2). 407–417. 24 indexed citations

17.

Geng, Yadi, Lei Yang, Chao Zhang, & Ling‐Yi Kong. (2014). Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells. Food and Chemical Toxicology. 73. 7–16. 36 indexed citations

18.

Jia, Yuanwei, et al.. (2014). aH nuclear magnetic resonance-based metabolomics reveals sex-specific metabolic changes of gastrodin intervention in rats. Asian Pacific Journal of Tropical Medicine. 7(10). 811–818. 3 indexed citations

19.

Li, Renshi, Xiaobing Wang, Xiaojun Hu, & Ling‐Yi Kong. (2013). Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters. 23(9). 2636–2641. 83 indexed citations

20.

Yao, Shun, Jian‐Guang Luo, Li Ma, & Ling‐Yi Kong. (2011). Two New Triterpenoid Saponins from the Roots ofGypsophila paniculata with Potent α-Glucosidase Inhibition Activity. Chinese Journal of Natural Medicines. 9(6). 401–405. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact